Other NAP books related by word and phrase frequencies

The following titles are likely to be of interest to you. The top keyword and keyphrase weights from this report have been compared with the equivalent lists of words and phrases for all other available NAP publications.

• Ensuring Safe Foods and Medical Products Through Stronger Regulatory Systems Abroad (ISBN ) Jim E. Riviere and Gillian J. Buckley, Editors; Committee on Strengthening Core Elements of Regulatory Systems in Developing Countries; Board on Global Health; Board on Health Sciences Policy; Institute of Medicine


• Building a National Framework for the Establishment of Regulatory Science for Drug Development:Workshop Summary (ISBN ) Yeonwoo Lebovitz, Rebecca English, and Anne Claiborne; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• The Future of Drug Safety: Promoting and Protecting the Health of the Public (ISBN ) Committee on the Assessment of the US Drug Safety System, Alina Baciu, Kathleen Stratton, Sheila P. Burke, Editors


• Challenges for the FDA: The Future of Drug Safety, Workshop Summary (ISBN ) Leslie Pray and Sally Robinson, Rapporteurs, Forum on Drug Discovery, Development, and Translation


• Advancing Regulatory Science for Medical Countermeasure Development: Workshop Summary (ISBN ) Theresa Wizemann, Bruce M. Altevogt, and Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Forum on Medical and Public Health Preparedness for Catastrophic Events; Institute of Medicine


• Accelerating the Development of New Drugs and Diagnostics: Maximizing the Impact of the Cures Acceleration Network: Workshop Summary (ISBN ) Steve Olson and Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy; Institute of Medicine


• Rare Diseases and Orphan Products: Accelerating Research and Development (ISBN ) Marilyn J. Field and Thomas F. Boat, Editors; Committee on Accelerating Rare Diseases Research and Orphan Product Development; Institute of Medicine


• Envisioning a Transformed Clinical Trials Enterprise in the United States: Establishing an Agenda for 2020: Workshop Summary (ISBN ) Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy; Institute of Medicine


• Ethical and Scientific Issues in Studying the Safety of Approved Drugs (ISBN ) Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs; Institute of Medicine


• Public Health Effectiveness of the FDA 510(k) Clearance Process: Balancing Patient Safety and Innovation: Workshop Report (ISBN ) Theresa Wizemann, Editor; Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process; Institute of Medicine


• The Development of Medications for the Treatment of Opiate and Cocaine Addictions:Issues for the Government and Private Sector (ISBN ) Carolyn E. Fulco, Catharyn T. Liverman, and Laurence E. Earley, Editors; Committee to Study Medication Development and Research at the National Institute on Drug Abuse, Institute of Medicine


• Breakthrough Business Models:Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary (ISBN ) Theresa Wizeman, Sally Robinson, and Robert Giffin, Forum on Drug Discovery, Development, and Translation, Institute of Medicine


• Opportunities to Address Clinical Research Workforce Diversity Needs for 2010 (ISBN ) Jong-on Hahm and Alexander Ommaya, Editors, Committee on Opportunities to Address Clinical Research Workforce Diversity Needs for 2010, Committee on Women in Science and Engineering, National Research Council


• Enhancing Food Safety:The Role of the Food and Drug Administration (ISBN ) Robert B. Wallace and Maria Oria, Editors; Committee on the Review of Food and Drug Administration's Role in Ensuring Safe Food; National Research Council


• Medical Devices and the Public's Health: The FDA 510(k) Clearance Process at 35 Years (ISBN ) Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process; Institute of Medicine


• Food and Drug Administration Advisory Committees (ISBN ) Richard A. Rettig, Laurence E. Earley, and Richard A. Merrill, Editors; Committee to Study the Use of Advisory Committees, Institute of Medicine


• Genome-Based Therapeutics:Targeted Drug Discovery and Development: Workshop Summary (ISBN ) Adam C. Berger and Steve Olson, Rapporteurs; Roundtable on Translating Genomic-Based Research for Health; Board on Health Sciences Policy; Institute of Medicine


• Nanotechnology and Oncology: Workshop Summary (ISBN ) Margie Patlak and Christine Micheel, Rapporteurs; Institute of Medicine


• Addressing the Threat of Drug-Resistant Tuberculosis:A Realistic Assessment of the Challenge: Workshop Summary (ISBN ) Robert Giffin and Sally Robinson, Rapporteurs; Institute of Medicine


• Understanding the Benefits and Risks of Pharmaceuticals: Workshop Summary (ISBN ) Forum on Drug Discovery, Development, and Translation, Leslie Pray, Rapporteur


• Safe and Effective Medicines for Children: Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act (ISBN ) Marilyn J. Field and Thomas F. Boat, Editors; Committee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA); Institute of Medicine


• Federal Agency Roles in Cancer Drug Development from Preclinical Research to New Drug Approval: The National Cancer Institute and the Food and Drug Administration (ISBN )


• Addressing the Barriers to Pediatric Drug Development: Workshop Summary (ISBN ) Cori Vanchieri, Adrienne Stith Butler, and Andrea Knutsen, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• Medical Countermeasures Dispensing:Emergency Use Authorization and the Postal Model: Workshop Summary (ISBN ) Clare Stroud, Lori Nadig, and Bruce M. Altevogt, Rapporteurs; Forum on Medical and Public Health Preparedness for Catastrophic Events; Institute of Medicine


• Biological Threats and Terrorism: Assessing the Science and Response Capabilities: Workshop Summary (ISBN ) Stacey L. Knobler, Adel A.F. Mahmoud, and Leslie A. Pray, Editors, Forum on Emerging Infections, Board on Global Health


• The Public Health Emergency Medical Countermeasures Enterprise:Innovative Strategies to Enhance Products from Discovery Through Approval: Workshop Summary (ISBN ) Theresa Wizemann, Clare Stroud, and Bruce M. Altevogt, Rapporteurs; Forum on Medical and Public Health Preparedness for Catastrophic Events; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• The Resistance Phenomenon in Microbes and Infectious Disease Vectors: Implications for Human Health and Strategies for Containment -- Workshop Summary (ISBN ) Stacey L. Knobler, Stanley M. Lemon, Marian Najafi, and Tom Burroughs, Editors, Forum on Emerging Infections


• Advancing Nuclear Medicine Through Innovation (ISBN ) Committee on State of the Science of Nuclear Medicine, National Research Council


• The National Cancer Policy Summit: Opportunities and Challenges in Cancer Research and Care: Workshop Summary (ISBN ) Margie Patlak, Sharyl J. Nass, and Erin Balogh, Rapporteurs; National Cancer Policy Forum; Institute of Medicine


• Assuring a Future U.S.-Based Nuclear and Radiochemistry Expertise (ISBN ) Committee on Assuring a Future U.S.-Based Nuclear Chemistry Expertise; Board on Chemical Sciences and Technology; Division on Earth and Life Studies; National Research Council


• Rational Therapeutics for Infants and Children:Workshop Summary (ISBN ) Sumner Yaffe, M.D., Editor; Ronald W. Estabrook, Peter Bouxsein, Sarah Pitluck, Jonathan R. Davis, Roundtable on Research and Development of Drugs, Biologics, and Medical Devices, Division of Health Sciences Policy


• Ensuring an Infectious Disease Workforce: Education and Training Needs for the 21st Century - Workshop Summary (ISBN ) Stacey L. Knobler, Thomas Burroughs, Adel Mahmoud, Stanley M. Lemon, Editors, Forum on Microbial Threats


• CNS Clinical Trials: Suicidality and Data Collection: Workshop Summary (ISBN ) Sarah Hanson, Miriam Davis, and Bruce Altevogt, Rapporteurs; Forum on Neuroscience and Nervous System Disorders


• Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease (ISBN ) Christine M. Micheel and John R. Ball, Editors; Committee on Qualifications of Biomarkers and Surrogate Endpoints in Chronic Disease; Institute of Medicine


• The Changing Economics of Medical Technology (ISBN ) Annetine C. Gelijns and Ethan A. Halm, Editors; Committee on Technological Innovation in Medicine, Institute of Medicine


• Accelerating the Development of Biomarkers for Drug Safety:Workshop Summary (ISBN ) Steve Olson, Sally Robinson, and Robert Giffin, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• Innovation and Invention in Medical Devices: Workshop Summary (ISBN ) Kathi E. Hanna, Frederick J. Manning, Peter Bouxsein, and Andrew Pope, Editors, Based on a Workshop of the Roundtable on Research and Development of Drugs, Biologics, and Medical Devices, Board on Health Sciences Policy


• Assessing and Improving Value in Cancer Care:Workshop Summary (ISBN ) Adam Schickedanz, Rapporteur; Institute of Medicine


• Standardizing Medication Labels:Confusing Patients Less, Workshop Summary (ISBN ) Lyla M. Hernandez, Rapporteur, Roundtable on Health Literacy


• Dietary Supplements: A Framework for Evaluating Safety (ISBN ) Committe on the Framework for Evaluating the Safety of the Dietary Supplements, National Research Council


• Policy Issues in the Development of Personalized Medicine in Oncology:Workshop Summary (ISBN ) Margie Patlak and Laura Levit, Rapporteurs; Institute of Medicine


• Facilitating Collaborations to Develop Combination Investigational Cancer Therapies: Workshop Summary (ISBN ) Margie Patlak, Erin Balogh, and Sharyl J. Nass, Rapporteurs; National Cancer Policy Forum; Institute of Medicine


• Countering the Problem of Falsified and Substandard Drugs (ISBN ) Lawrence O. Gostin and Gillian J. Buckley, Editors; Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products; Board on Global Health; Institute of Medicine


• Improving the Quality of Cancer Clinical Trials:Workshop Summary (ISBN ) Margie Patlak and Sharyl Nass, Rapporteurs


• Transforming Clinical Research in the United States:Challenges and Opportunities: Workshop Summary (ISBN ) Rebecca English, Yeonwoo Lebovitz, and Robert Griffin, authors; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• Diffusion and Use of Genomic Innovations in Health and Medicine:Workshop Summary (ISBN ) Lyla M. Hernandez, Rapporteur, Roundtable on Translating Genomic-Based Research for Health


• Safe Medical Devices for Children (ISBN ) Marilyn J. Field and Hugh Tilson, Editors, Committee on Postmarket Surveillance of Pediatric Medical Devices


• The New Profile of Drug-Resistant Tuberculosis in Russia: A Global and Local Perspective: Summary of a Joint Workshop (ISBN ) Steve Olson, Rebecca English, and Anne Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Institute of Medicine; Russian Academy of Medical Sciences


• Emerging Safety Science: Workshop Summary (ISBN ) Sally Robinson, Robert Pool, and Robert Giffin, Forum on Drug Discovery, Development, and Translation, Institute of Medicine


• Informatics Needs and Challenges in Cancer Research: Workshop Summary (ISBN ) Sharyl J. Nass and Theresa Wizemann, Rapporteurs; National Cancer Policy Forum; Board on Health Care Services; Institute of Medicine